中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
45期
51-51
,共1页
扁桃体癌%放射治疗%微波治疗%疗效
扁桃體癌%放射治療%微波治療%療效
편도체암%방사치료%미파치료%료효
目的:探讨放疗联合微波治疗扁桃体恶性肿瘤的临床疗效。方法选取我院在2010年9月~2013年9月收治的68例扁桃体恶性肿瘤患者作为研究对象,随机将其分为A组和B组(每组34例),A组患者实施微波治疗,B组患者在微波治疗基础上,辅以放射治疗,对比两组患者的治疗效果。结果 A组患者的完全缓解率、总有效率均显著低于B组,差异具有统计学意义,P>0.05;两组患者的不良反应发生率比较,差异无统计学意义,P>0.05。结论在扁桃体癌的临床治疗中,同时实施放疗和微波治疗,二者可发挥协同作用,提高治疗效果,热疗-放疗综合疗法是治疗扁桃体恶性肿瘤的理想方法,值得推广应用。
目的:探討放療聯閤微波治療扁桃體噁性腫瘤的臨床療效。方法選取我院在2010年9月~2013年9月收治的68例扁桃體噁性腫瘤患者作為研究對象,隨機將其分為A組和B組(每組34例),A組患者實施微波治療,B組患者在微波治療基礎上,輔以放射治療,對比兩組患者的治療效果。結果 A組患者的完全緩解率、總有效率均顯著低于B組,差異具有統計學意義,P>0.05;兩組患者的不良反應髮生率比較,差異無統計學意義,P>0.05。結論在扁桃體癌的臨床治療中,同時實施放療和微波治療,二者可髮揮協同作用,提高治療效果,熱療-放療綜閤療法是治療扁桃體噁性腫瘤的理想方法,值得推廣應用。
목적:탐토방료연합미파치료편도체악성종류적림상료효。방법선취아원재2010년9월~2013년9월수치적68례편도체악성종류환자작위연구대상,수궤장기분위A조화B조(매조34례),A조환자실시미파치료,B조환자재미파치료기출상,보이방사치료,대비량조환자적치료효과。결과 A조환자적완전완해솔、총유효솔균현저저우B조,차이구유통계학의의,P>0.05;량조환자적불량반응발생솔비교,차이무통계학의의,P>0.05。결론재편도체암적림상치료중,동시실시방료화미파치료,이자가발휘협동작용,제고치료효과,열료-방료종합요법시치료편도체악성종류적이상방법,치득추엄응용。
objective: to study the clinical curative effect of radiotherapy combined microwave tonsil malignant tumor. Selection methods: our hospital in September 2010 to September 2013 were 68 tonsil malignant tumor patients as the research object, its randomly divided into group A and group B (34 cases) in each group, patients in group A of the microwave treatment, B group of patients based on the microwave treatment, complementary with radiation therapy, comparing the therapeutic effect of two groups of patients. Results: A group of patients with complete remission rate and total effective rate were significantly lower than that of group B, the difference is statistical y significant, P > 0.05; The incidence of adverse reactions compared two groups of patients, there was no statistical y significant difference, P > 0.05). Conclusions: in clinical treatment of tonsil ar cancer, implementation of radiation and microwave treatment at the same time, the two can create synergies and improve the effect of treatment, heat treatment - comprehensive radiation therapy is an ideal method to treat tonsil malignant tumor, is worthy of popularization and application.